Search Results

1 - 10 of 53 items :

  • "management" x
Clear All
The 4th JEPE (journees d’echanges avec les pays de l’est) one model of pneumological exchange of two medicine schools

On 10–12 May 2019, the 4th JEPE conference with the APGS (Association Pneumologique de Grande Sud) and APPEN (Association des Pneumologues de Pays de L’Est du Nord Pas de Calais) was organized. At the same time, it was the first Franco-Italian meeting of the APGS association which took place during the 4th JEPE in Stresa, Italy. The theme of the congress was “The management of Chronic Respiratory Diseases (Asthma, COPD, SAOS) in France and Italy” with the contribution of “Association Asthme et Allergies, OSPL, Apnee de Sommeil.” This support was

Open access
Pneumonia by Kocuria rosea: case report and literature review

urgently needed as no management guidelines or antimicrobial susceptibility cutoff points are currently available regarding this bacterial genus, which is why as there has been a significant increase in Kocuria infection during the last 10 years. This article presents the case of a 71-year-old patient having a background of diabetes mellitus and chronic obstructive pulmonary disease who was admitted to a tertiary hospital because of severe community-acquired pneumonia (CAP) caused by Kocuria rosea ; he responded favourably to antibiotic management. An exhaustive

Open access
Asthma–COPD–Bronchiectasis combination: an unstudied triplet

therapeutic management. A 28.4% prevalence of bronchiectasis reported in uncontrolled moderate-to-severe asthma ( 2 ), means that one in three asthma patients experiences this type of association. Previous studies revealed that the association is related to the severity of asthma, the presence of chronic expectoration, lower levels of fractional exhaled nitric oxide (Fe NO), and a previous history of pneumonia ( 3 ). In the literature, the prevalence of bronchiectasis among patients with asthma ranges from 2.2% ( 4 ) to 77% ( 5 ). This broad variation is caused by some

Open access
Awake sedation thoracoscopy for the diagnosis of malignant mesothelioma: a service review

-6196(12)60212-2 Prakash UBS Reiman HM Comparison of needle-biopsy with cytologic analysis for the evaluation of pleural effusion – analysis of 414 cases Mayo Clinic Proceedings 1985 60 3 158 164 6 Rodriguez-Panadero F, Janssen JP, Astoul P. Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion. European Respiratory Journal 2006;28(2):409–421. 10.1183/09031936.06.00013706 Rodriguez-Panadero F Janssen JP Astoul P Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion European

Open access
Sleep apnea syndrome and heart failure—mechanisms and consequences

Undiagnosed and untreated SAS increase morbidity and mortality in HF patients and represent a significant burden on the healthcare system, with more costs and resources utilization, emphasizing the importance of early diagnosis of this disease. This might require introduction of SAS screening as a routine method in the management of patients with HF. Ethics approval and consent to participate Not applicable. Competing interests The authors declare that they have no competing interests. References 1 Punjabi NM. The epidemiology of adult

Open access
Hypersensitivity pneumonitis in a teenager

pneumonitis: perspectives in diagnosis and management. American Journal of Respiratory and Critical Care Medicine 2017;196(6):680–689. 28598197 10.1164/rccm.201611-2201PP Vasakova M Morell F Walsh S Leslie K Raghu G Hypersensitivity pneumonitis: perspectives in diagnosis and management American Journal of Respiratory and Critical Care Medicine 2017 196 6 680 689 7 Fishman A. et al. Hypersensitivity pneumonitis. Fishman’s Pulmonary Disease and Disorder 2008:1161–1172. Fishman A. et al Hypersensitivity pneumonitis Fishman

Open access
Decreased plasma epidermal growth factor (EGF) levels in patients with severe chronic obstructive pulmonary disease

This work was personally funded without any grant. References 1 Quaderi SA, Hurst JR. The unmet global burden of COPD. Global Health, Epidemiology and Genomics 2018;3:e4–e4. 29868229 10.1017/gheg.2018.1 Quaderi SA Hurst JR The unmet global burden of COPD Global Health, Epidemiology and Genomics 2018 3 e4 e4 2 Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory

Open access
Genetics and inflammatory profile in tobacco dependence

-035MS 16113470 van Eeden SF Yeung A Quinlam K Hogg JC Systemic response to ambient particulate matter: Relevance to chronic obstructive pulmonary disease Proceedings of the American Thoracic Society 2005 2 1 61 67 21 Todea D, Cosma C, Dicu T, Rosca L, Dinu AC, Risteiu M, et al. Lung cancer risk induced by residential radon in CLUJ and Alba Counties, ROMANIA. Environmental Engineering and Management Journal . 2013;12(6): 1281–1285. 10.30638/eemj.2013.157 Todea D Cosma C Dicu T Rosca L Dinu AC Risteiu M et al Lung

Open access
Prognosing a severe course of asthma in children following the study of endothelial function

: Nutritional prevention and intervention. Therapeutics and Clinical Risk Management 2016;12: 361–372. 27022267 Hendaus MA Jomha FA Ehlayel M Allergic diseases among children: Nutritional prevention and intervention Therapeutics and Clinical Risk Management 2016 12 361 372 3 Alagappan VK, de Boer WI, Misra VK, Mooi WJ, Sharma HS. Angiogenesis and vascular remodeling in chronic airway. Cell Biochemistry and Biophysics 2013;67: 219–234. 23975597 10.1007/s12013-013-9713-6 Alagappan VK de Boer WI Misra VK Mooi WJ Sharma HS

Open access
Risk for stroke and chronic kidney disease in patients with sleep apnea syndrome and heart failure with different ejection fractions

underlying cause of HF or it was a consequence of HF; thus, some studies demonstrated that EF decreased through the progression of valvular insufficiency. If SAS is a truly established independent cardiometabolic risk factor and if SAS should be included in integrated cardiometabolic risk reduction management are questions still waiting for definitive answers ( 28 ). Conclusions Patients with SAS and HFpEF have been shown to be at a higher risk for stroke. CKD and aortic and tricuspid insufficiency are higher in the group with reduced EF compared to those with SAS

Open access